KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 2.955 21 days ( -33.58 % )
Last Price $14.52 -1.69 %
High/ Low $14.07 - $14.82 1.37%
Chg 7 Days -4.60 % $15.22 $14.52
Chg 30 Days 43.90 % $10.09 $14.52
Chg 12 mos 1,736.12 % $0.791 $14.52
Trend - 3 mos 54.02 % Width: 48.85 %
Trend - 12 mos 1,264.96 % Width: 80.79 %
Pred. range - 3 mos $18.88 - $28.10 30.03 % - 93.54 %
Pred. range - 12 mos $133.75 - $241.81 821.16 % - 1,565.38 %
Short MA avg 3 mos Buy Apr 16, 2024 - 8 days
Long MA avg 3 mos Sell Mar 25, 2024 - 23 days
Short/Long MA avg 3 mos Buy Mar 08, 2024 - 34 days
Short MA avg 12 mos Sell Apr 24, 2024 - 2 days
Long MA avg 12 mos Sell Mar 25, 2024 - 23 days
Short/Long MA avg 12 mos Buy Apr 02, 2024 - 18 days
Pivot Short Sell Apr 05, 2024 - 15 days
Bollinger Buy Apr 01, 2024 - 19 days
MACD Sell No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Curis

Curis Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myeloid leukemia and myelodysplastic syndromes; and CI-8993, a monoclonal antibody designed to antagonize t... CRIS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT